Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The MCPP challenge test in schizophrenia: hormonal and behavioral responses.

N Iqbal1, G M Asnis, S Wetzler

  • 1Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10467.

Biological Psychiatry
|October 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical and Physical Characterization of a Biphasic 3D Printed Silk-Infilled Scaffold for Osteochondral Tissue Engineering.

ACS biomaterials science & engineering·2024
Same author

How does VAAFT fit into the world of clinical and academic anal fistula?

Techniques in coloproctology·2022
Same author

Differences in gender perception of smokeless tobacco.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Do you know when the inhaler is empty?

Archives of disease in childhood·2022
Same author

Unusual semiconductor-metal-semiconductor transitions in magnetite Fe<sub>3</sub>O<sub>4</sub> nanoparticles.

RSC advances·2022
Same author

Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients.

New microbes and new infections·2021
Same journal

Impact of Transcranial Direct Current Stimulation-Induced Electric Fields on Slowing Cognitive Decline in Older Adults With Mild Cognitive Impairment or Remitted Major Depressive Disorder: An Analysis of the PACt-MD Randomized Clinical Trial.

Biological psychiatry·2026
Same journal

Remembering Jon-Kar Zubieta, M.D., Ph.D.

Biological psychiatry·2026
Same journal

Kappa opioid receptor availability in borderline personality disorder: An in-vivo investigation with [<sup>11</sup>C]EKAP PET imaging.

Biological psychiatry·2026
Same journal

From Satiety to Substance Use: Neural Mechanisms of GLP-1 Signaling in Appetite and Reward.

Biological psychiatry·2026
Same journal

Distinct and Shared Molecular Mechanisms Underlie Morphological-Functional Overcoupling and Undercoupling in Major Depressive Disorder.

Biological psychiatry·2026
Same journal

Dynamic Brain States With Cannabis Intoxication: Beyond "More Is Better" in Interpreting Brain Connectivity.

Biological psychiatry·2026
See all related articles

Schizophrenia patients showed worsened symptoms and lower hormonal responses to m-chlorophenylpiperazine (MCPP), a serotonin agonist. These findings suggest altered serotonin receptor sensitivity in schizophrenia.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Schizophrenia is a complex psychiatric disorder with significant neurobiological underpinnings.
  • Serotonin (5-hydroxytryptamine, 5HT) systems are implicated in the pathophysiology of schizophrenia.
  • Neuroendocrine challenge paradigms are used to probe neurotransmitter system function in psychiatric conditions.

Purpose of the Study:

  • To investigate the neuroendocrine and behavioral responses to m-chlorophenylpiperazine (MCPP) in male schizophrenic patients compared to healthy controls.
  • To explore the role of serotonin 5HT receptor sensitivity in schizophrenia.

Main Methods:

  • A placebo-controlled, double-blind study administering MCPP (0.25 mg/kg orally) to schizophrenic patients (n=7) and normal male controls (n=8).

Related Experiment Videos

  • Assessment of behavioral changes using the Positive and Negative Syndrome Scale (PANSS).
  • Measurement of hormonal variables including cortisol and prolactin levels over 210 minutes post-administration.

    • Main Results:

    • Schizophrenic patients exhibited an overall exacerbation of psychopathology, particularly positive symptoms and activation, after MCPP administration compared to placebo.
    • Significantly lower cortisol and prolactin responses were observed in schizophrenic patients compared to controls.
    • While not statistically significant, schizophrenic patients showed lower peak MCPP blood levels.

    Conclusions:

    • MCPP administration exacerbates psychopathology in schizophrenia, indicating potential alterations in serotonin 5HT receptor function.
    • Blunted cortisol and prolactin responses suggest dysregulation of the neuroendocrine system in schizophrenia.
    • The findings highlight the importance of considering serotonin system sensitivity and MCPP pharmacokinetics in schizophrenia research.